Clinical Trials

Back to Clinical Trials Overview

Back To Cancer Clinical Trials

Your search for "Urinary Bladder" returned 4 results:

Multi-center Phase 2 Trial of Single-agent Amrubicin as second-line therapy in patients with Advanced/Metastatic Refractory Urothelial Carcinoma
Principal Investigator(s): Matthew Galksy

A Randomized, Phase 2, Open Label Study Evaluating DN24-02 as Adjuvant Therapy in Subjects with High Risk HER2+ Urothelial Carcinoma
Principal Investigator(s): Simon J. Hall

Phase II Trial of Everolimus or Everolimus plus Paclitaxel as First-line Therapy in Cisplatin-ineligible Patients with Advanced Urothelial Carcinoma
Principal Investigator(s): Matthew Galsky

Multi-Center Phase IB/II Trial of Gemcitabine, Cisplatin, Plus Lenalidomide as First-Line Therapy for Patients with Metastatic Urothelial Carcinoma
Principal Investigator(s): Matthew Galsky